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The hepatitis B virus X protein (HBx) is essential for establishing natural viral infection and has been implicated in the
development of liver cancer associated with chronic infection. The basis for HBx function in either process is not understood.
In cell culture, HBx exhibits pleiotropic activities affecting transcription, DNA repair, cell growth, and apoptotic cell death.
Numerous cellular proteins including the p127-kDa subunit of UV-damaged DNA-binding activity have been reported to
interact with HBx but the functional significance of these interactions remains unclear. Here we show that the binding of HBx
to p127 interferes with cell viability. Mutational analysis reveals that HBx contacts p127 via a region to which no function has
been assigned previously. An HBx variant bearing a single-charge reversal substitution within this region loses p127 binding
and concomitant cytotoxicity. This mutant regains activity when directly fused to p127. These studies confirm that p127 is an
important cellular target of HBx, and they indicate that HBx does not exert its effect by sequestering p127, and thereby
preventing its normal function, but instead by conferring to p127 a deleterious activity. © 2001 Academic Press
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Persistent infection with hepatitis B virus (HBV) is
strongly associated with development of liver diseases
including hepatocellular carcinoma (HCC). HBV encodes
a small regulatory protein known as hepatitis B viral X
protein (HBx) that is well conserved among all mamma-
lian hepatitis viruses. The importance of HBx in the viral
life cycle has been demonstrated in woodchucks (Chen
et al., 1993; Zoulim et al., 1994) and its contribution to
HCC is supported by a number of circumstantial lines of
evidence (for a review, see Seeger and Mason, 2000). Yet
the underlying molecular functions of HBx in these two
processes remain unknown.
HBx has been reported to bind to a number of unre-
lated cellular factors and in cell culture it behaves as a
multifunctional protein with activities affecting transcrip-
tion, cell signaling, DNA repair, cell growth, and apopto-
tic cell death. The protein is believed to exert a pleiotro-
pic transcription effect through interactions with compo-
nents of the basal transcription machinery and
regulatory factors, or by activating various signal trans-
duction pathways, including the Ras-Raf-MAP kinase
signaling cascade, the protein kinase C cascade, and
the Jak1-STAT signaling pathway (for reviews, see An-
drisani and Barnabas, 1999; Arbuthnot et al., 2001). Yet
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266HBx was also found to interfere with DNA repair through
interactions with DNA repair factors (Capovilla et al.,
1997; Jia et al., 1999), to bind proteasome subunits and
alter the function of the proteasome (Sirma et al., 1998;
Hu et al., 1999), or to associate with p53 and block its
entry into the cell nucleus, thereby preventing its anti-
proliferative effect (Arbuthnot et al., 2001). Whether any of
these activities explains HBx ability to either drive ar-
rested cells to divide (Koike et al., 1994; Benn and
Schneider, 1995; Chirillo et al., 1997) or trigger apoptosis
(Chirillo et al., 1997; Su and Schneider, 1997; Kim et al.,
1998; Terradillos et al., 1998; Shintani et al., 1999), a
property that may relate to its transforming potential
observed under certain experimental conditions (Hohne
et al., 1990; Kim et al., 1991; Ueda et al., 1995; Terradillos
et al., 1997), remains to be clarified.
HBx has been known for some time to interact with the
p127-kDa subunit of the UV-damaged DNA-binding ac-
tivity (UV-DDB) (Lee et al., 1995; Sitterlin et al., 1997), but
the significance of this interaction has remained quite
elusive. UV-DDB consists of a heterodimer of p127 (or
DDB1) and a p48-kDa protein (or DDB2) that mediates
nuclear import (Keeney et al., 1993; Fujiwara et al., 1999;
Shiyanov et al., 1999). The damaged-DNA binding func-
tion of UV-DDB requires both subunits and is absent in
some cancer-prone disease xeroderma pigmentosum
group E (XP-E) patients due to mutations of the p48 gene
(Chu and Chang, 1988; Nichols et al., 1996; Hwang et al.,
1998). Although UV-DDB has a DNA repair function
(Keeney et al., 1994; Rapic Otrin et al., 1998; Tang et al.,
2000), a role other than DNA repair has also been sug-
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267BINDING OF HBx TO p127 UV-DDB AFFECTS CELL SURVIVALgested (see Discussion). In this study we show that the
binding of HBx to p127 interferes with cell viability. Our
results suggest that HBx acts by conferring to p127
abnormal activities rather than by preventing its normal
function. The possible implications of these findings for
an involvement of HBx in the pathogenesis of liver can-
cer are discussed.
RESULTS
HBx induces a loss of cell viability
A simple model for an involvement of HBx in liver
carcinogenesis is that its essential function for viral in-
fectivity incidentally translates into a tumor promoting
activity at some point during chronic infection. We inves-
tigated the ability of HBx to transform preneoplastic,
immortalized cell lines such as Rat1 or NIH3T3 mouse
fibroblasts by a conventional focus-formation assay and
by colony formation in soft agar. We obtained no evi-
dence that expression of HBx reproducibly induces
transformation in these cells. We also tested HBx for its
ability to cooperate with known oncogenes such as H-
ras, E1A, or c-myc in eliciting cellular transformation in
primary rat embryo fibroblasts (REFs). Whereas cells
coexpressing H-ras and E1A, or H-ras and c-myc, exhib-
ited a clear transformed phenotype, none of the three
combinations involving HBx produced foci or colonies in
soft agar above background levels (data not shown).
Thus, in agreement with other reports (Kim et al., 1998;
Schuster et al., 2000), we conclude that HBx exhibits no
obvious transforming properties.
In the course of these studies, we unexpectedly found
that HBx actually prevents cooperating oncogenes from
inducing transformed foci in primary REF cells. This
inhibition reflects the ability of HBx to suppress clonal
outgrowth of these cells as revealed by a colony-forma-
tion assay. Figure 1A shows that coexpression of HBx
together with H-ras, E1A, and the puromycin resistance
gene dramatically reduces the number of drug-resistant
colonies. The effect is dependent on the HBx protein
because no suppression is observed with a control vec-
tor carrying a frameshift mutation inserted 10 codons
downstream of the initiator ATG (Fig. 1A). Similar activi-
ties were found in various established cell lines, includ-
ing HeLa (Fig. 1B) and the human hepatoblastoma cell
line HepG2 (data not shown), and with both native HBx
and a variant bearing the enhanced green fluorescent
protein (GFP) at the amino-terminus (Fig. 1B). Micro-
scopic analysis revealed that most cells expressing HBx
rapidly exhibit an altered morphology and die between 5
and 7 days after transfection. Hence, HBx affects survival
of both primary and immortalized cells via a mechanism
that is dominant over the proliferative effects of H-ras,
E1A, and c-myc oncogenes. This property has been re-
cently reported to reflect the ability of HBx to induce
apoptotic cell death (Arbuthnot et al., 2001).HBx interacts with the p127-kDa subunit of UV-DDB in
yeast
To identify and characterize cellular proteins that spe-
cifically interact with HBx, we performed an extensive
two-hybrid protein interaction screen in the yeast Sac-
charomyces cerevisiae. As bait, we used the full-length
viral protein fused to either the amino- or carboxyl-termi-
nus of RFX, a human DNA-binding protein with no tran-
scriptional activity in yeast (see Materials and Methods).
We screened a total of 15 3 106 primary transformants
hat were derived from two independent VP16 activation
omain-tagged human cDNA libraries. Several cDNA
lones were isolated from both libraries that scored
ositive after rescue in Escherichia coli and retransfor-
ation back into yeast. All of them corresponded to the
ame mRNA encoding the p127 subunit of UV-DDB
Takao et al., 1993; Hwang et al., 1996). These results
independently confirm the previously reported interac-
tion of HBx with p127 in yeast (Lee et al., 1995; Sitterlin et
al., 1997) using a very different two-hybrid system.
Intriguingly, all cDNA inserts contained the entire p127
open reading frame, despite the fact that one library was
constructed with randomly primed cDNA fragments hav-
ing an average length (;2.3 kb) that is significantly
shorter than that of p127 mRNA ($4.2 kb). This suggests
that both the amino- and carboxyl-terminal regions of
p127 are important for interaction with HBx. To address
FIG. 1. HBx suppresses colony formation in both primary and immor-
talized cells. (A) Primary rat embryo fibroblasts (REFs) cotransfected
with the puromycin resistance gene and equal amounts of H-ras, E1A,
and the indicated plasmids were cultured in a medium containing
puromycin to assess for drug-resistant colony formation. Colonies were
stained with crystal violet 2 weeks later. HBx(fs) carries a frameshift
mutation inserted 10 codons downstream of the initiator ATG. (B)
Nontransfected HeLa cells (n.t.), or cells transfected with the episomal
Epstein–Barr virus-based expression vector EBO-76PL bearing a hy-
gromycin resistance gene (vect), or with derivatives thereof producing
the indicated proteins, were selected with hygromycin for resistant
colonies. When not expressed from the episomal vector, an enhanced
green fluorescent protein (GFP) gene was cotransfected to assess for
comparable transfection efficiencies by fluorescence-activated cell
sorter (FACS) analysis. Drug-resistant colonies were fixed and stained
with crystal violet 11 days after transfection. GFP-HBx designates a
hybrid protein carrying the GFP at the amino terminus.this issue directly, we generated truncation mutants of
p127. These mutants were tested for interaction with HBx
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268 LIN-MARQ ET AL.using the two-hybrid system in a yeast strain carrying an
RFX-dependent LacZ reporter gene. Figure 2 shows that,
as expected, full-length p127 interacts with both RFX-HBx
and HBx-RFX fusion proteins. In contrast, none of the
p127 truncations retain HBx binding activity. Immunoblot-
ting with antibodies against p127 [a kind gift from V.
Rapic Otrin (University of Pittsburgh)] readily detected
the carboxyl-terminal deletion, which is expressed at
higher levels compared to the wild-type protein, but none
of the amino-terminal truncations (data not shown).
These results indicate that the amino-terminal region is
required for stability of p127 in yeast and that the car-
boxyl-terminal portion of the protein is essential for the
interaction with HBx.
HBx binds to p127 through a hitherto unrecognized
region
We next mapped the minimal region of HBx required
for interaction with p127 by testing several amino- and
carboxyl-terminal truncations in the yeast two-hybrid sys-
tem. To avoid steric hindrance between the p127-binding
motif of HBx and flanking RFX sequences, the amino-
terminal truncations were connected to the N-terminus of
RFX, and the carboxyl-terminal deletions were fused C-
terminal to RFX. These studies delimit a p127-interaction
domain within HBx lying between amino acids 76 and
FIG. 2. Interaction of HBx with the p127-kDa UV-DDB protein in a
east two-hybrid assay. Full-length (1–1140) and p127 deletion mutants
runcated at the indicated amino acids were fused to the VP16 activa-
ion domain and tested for interaction with HBx linked to either the
arboxyl-terminus (RFX-HBx) or the amino-terminus (HBx-RFX) of RFX.
FX is a human DNA-binding protein with no transcriptional activity in
east (Gonzalez-Couto et al., 1997). The gray horizontal bars on the
right represent the relative activities of a lacZ reporter gene bearing a
single RFX-binding site in strains expressing the indicated HBx fusion
proteins alone or together with the p127 variants depicted beside.
Immunoblotting with antibodies against residues 408–425 of p127 (a
kind gift from V. Rapic Otrin) detected higher levels of the carboxyl-
terminal deletion compared to the wild-type protein but none of the
mutants lacking the amino-terminal region, indicating that this region is
required for stable expression of p127 in yeast (data not shown).125 (Fig. 3A). A truncated version of HBx that contains
only this region indeed retains the ability to interact withp127, whereas a shorter fragment spanning residues 76
to 110 does not (Fig. 3A).
To identify residues directly involved in the interaction
with p127, we generated a series of point mutants within
the minimal p127-binding domain. Only charged resi-
dues were targeted for mutagenesis because they are
more likely to be exposed on the surface of the protein.
They were mutated either to alanine to remove the side
chain or to an amino acid of the opposite charge. Only
one variant exhibits strongly reduced binding activity
when bearing alanine substitutions and no activity at all
when the wild-type residues are replaced by amino acids
of the opposite charge (K95E/R96E in Fig. 3B). A L98F
substitution obtained as a consequence of a PCR error
also shows markedly decreased p127-binding activity.
Strikingly, the defective HBx variants bear amino acid
substitutions that fall within a short, reportedly nones-
sential segment delineated by the only two arginine-
proline insertion mutations that were found by others to
have no effect on p127-binding activity (Sitterlin et al.,
1997). To examine which of the two residues at positions
95 and 96 are key determinants for HBx association with
p127, we mutated them individually. Figure 3B reveals
that a charge reversal mutation at position 96 of HBx
suffices to abolish p127 binding. Remarkably, the same
substitution introduced at the adjacent position produces
an HBx derivative that retains full ability to interact with
p127. These results strongly suggest that residue R96
contributes in a critical fashion to the specificity of HBx/
p127 complex formation by serving as a major contact
point between the two proteins.
HBx-mediated cell death requires interaction with p127
Next, we assessed whether HBx and p127 can interact
in mammalian cells. We found that in cotransfection
experiments the two proteins mutually stabilize each
other. As shown in Fig. 4A, coexpression of p127 in HeLa
cells leads to increased levels of native HBx but has no
appreciable effect on the HBx(R96E) mutant that is de-
fective for p127 binding in yeast. Conversely, only wild-
type HBx, but not HBx(R96E), induces accumulation of
the p127 protein. This effect is direct and specific for
p127 because no increase is observed with an unrelated
protein produced from the same vector, arguing against
a transcriptional effect of HBx (data not shown). These
results are fully consistent with HBx and p127 forming a
complex in mammalian cells. The finding that the two
HBx variants exhibit similar stability in the absence of
ectopic p127 (Fig. 4A and see below) suggests that only
low amounts of endogenous p127 are available for inter-
action with wild-type HBx, thereby allowing stabilization
of only a minor fraction of the viral protein.
To investigate the biological activities of HBx in rela-
tion to its interaction with p127, we tested the various
HBx point mutants for their ability to interfere with cell
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269BINDING OF HBx TO p127 UV-DDB AFFECTS CELL SURVIVALviability as measured by the colony formation assay.
Figure 4B shows that the HBx mutants that are deficient
for p127 binding in yeast do not cause a substantial
reduction in the number of colonies. In particular,
HBx(R96E) is defective in this assay. By contrast, the
p127-binding-proficient variants, including the adjacent
HBx(K95E) mutant, demonstrate a strong suppression of
colony formation comparable to the wild-type protein.
Mutant HBx(K113E;D114R) is an exception in that it ex-
hibits an intermediate phenotype. This latter derivative
may be either mildly affected in its interaction with p127
(Fig. 3B) or impaired in another, yet to be discovered HBx
function. That the loss in activity does not merely reflect
an instability of the defective proteins is demonstrated by
the Western blot analysis presented in Fig. 4C. Notably,
the functionally defective HBx(R96E) derivative accumu-
lates to levels comparable to the wild-type protein and
significantly higher than the mutant HBx(D107R), which
retains full activity. These results strongly suggest that
p127 is a functionally relevant HBx target.
One mechanism whereby HBx may exert its effect is
by sequestering p127, thereby preventing it from perform-
ing a function that might be essential for cell survival. A
prediction of this model is that an excess of p127 should
restore cell viability by titrating out HBx. We thus tested
the effect of p127 overexpression on HBx activity and
found, as shown in Fig. 5A, that it does not overcome
growth suppression in the colony formation assay. This
result suggests instead that HBx may act by causing
p127 to carry out an inappropriate activity. In this case,
compensating for the p127-binding defect should restore
the ability of a p127-binding-deficient HBx mutant to
interfere with cell viability. Figure 5A reveals, however,
that overexpression of p127 does not suffice to confer
RFX and tested for interaction with p127 in yeast by comparing RFX-
dependent b-galactosidase activity in cells expressing the indicated mu-
tants alone (2) or together (1) with the VP16-p127 hybrid protein (lower
left). The effect of a double-alanine substitution at position 95 and 96 and
of single charge reversal mutations at these positions is illustrated at right.
The consequence of insertion mutations on HBx binding to p127 was
reported by others (Sitterlin et al., 1997). Mutations strongly affecting
127-binding activity are indicated in black, and mutations with minor or no
ffect on HBx activity are represented in gray. (C) Comparison of the amino
cid sequences of the X proteins encoded by (from top to bottom): human
BV subtype ayw (GenPept Accession No. QQVLD1), chimpanzee HBV
GenBank Accession No. P12912), woodchuck hepatitis virus (P03167), and
round squirrel hepatitis virus (AAA46758). The sequence alignment was
erformed using the MAP program (Huang, 1994). Gaps (2) are intro-
uced to maximize alignment. Residue numbers refer to the human HBx
equence. Identical residues in proteins are shown white on black. Con-
ervative amino acid substitutions are shown on a gray background. The
wo regions previously reported to be crucial for HBx activities and inter-
ctions with cellular proteins are indicated by hatched boxes. Residues
hat were mutated in this study are designated with asterisks. The argin-
ne–proline insertion mutations are represented as in (B). A potential
econdary structure of the HBx region interacting with p127 is depictedFIG. 3. Mapping of residues within HBx critical for association with
p127. (A) Full-length (1–154) and HBx deletion mutants truncated at the
indicated amino acids were tested for interaction with p127 using the
RFX-based yeast two-hybrid system as in Fig. 2. An interaction is
scored positive (1) if b-galactosidase activity in cells expressing the
wo hybrid proteins reaches higher levels than in cells expressing the
elevant HBx fusion protein alone. This latter control is important
ecause certain HBx truncations fused to RFX were found to stimulate
acZ expression by themselves. (B) Sequence of the p127-interaction
omain and HBx point mutants. Triangles above the sequence corre-
pond to arginine–proline (RP) insertion mutations reported previouslyelow the sequences, with a-helices predicted by various algorithms
delineated as open tubes. See Discussion for a detailed description.
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270 LIN-MARQ ET AL.cytotoxic properties to the HBx(R96E) mutant. This indi-
cates that the mutant is severely compromised for p127
binding. To circumvent this problem, we artificially teth-
ered the HBx mutant to its cellular target. Remarkably,
FIG. 4. Functional analyses of HBx and point mutant derivatives in
ammalian cells. (A) HBx and p127 mutually stabilize each other. HeLa
ells were cotransfected with constructs encoding N-terminal GFP
usions of either wild-type HBx, the p127-binding defective HBx(R96E)
utant, or p127, and equal amounts of either vector control (1vect) or
xpression plasmids producing the indicated proteins. Transfection
fficiencies were comparable as assessed by FACS analysis (data not
hown). Cell lysates were prepared 24 h (GFP-p127) or 72 h (GFP-HBx
nd GFP-HBx(R96E)) after transfection. The levels of GFP fusion pro-
eins expression were detected by Western blot analysis performed
ith anti-GFP antibodies. (B) HBx-mediated suppression of colony
ormation correlate with binding to p127. HeLa cells were transfected
ith EBO-76PL-derived episomal vectors expressing the indicated HBx
ariants along with a plasmid encoding GFP to assess for transfection
fficiencies by FACS analyses. Colony formation assay was performed
s in Fig. 1B. (C) Expression levels of HBx and point mutant derivatives.
eLa cells were transiently transfected with constructs expressing the
ndicated HBx variants fused N-terminal to GFP. At 24 h posttransfec-
ion, cells were analyzed by FACS to assess for transfection efficien-
ies, and cell lysates were prepared. Western blot analysis was per-
ormed using an antibody directed against GFP. Equal protein amounts
ere loaded in each lane as judged by Coomassie staining and
mmunoblotting with an antibody recognizing an unrelated protein (data
ot shown).connecting p127 to the otherwise inactive HBx(R96E)
derivative rescues much of its activity (Fig. 5B). The effect
a
Cis dependent on the HBx sequence because a GFP-
containing version of p127 exhibits no such properties
(Fig. 5B). The HBx-p127 fusion proteins are expressed to
levels comparable to endogenous p127, and they induce
the same morphological changes and promote cell death
5 to 7 days after transfection as observed with HBx,
suggesting that they act through similar mechanisms as
the native HBx/p127 complex (data not shown). These
results provide direct evidence that the defect of
HBx(R96E) is specifically caused by its inability to effi-
ciently interact with p127 and hence that an interaction of
HBx with this protein is critical for its activity. As
HBx(R96E) cannot associate with free p127, they also
indicate that the corresponding fusion protein manifests
its effect without interfering with the endogenously ex-
pressed protein. Taken together, these results identify
p127 as an important cellular target of HBx, and they
FIG. 5. HBx confers to p127 abnormal activities rather than prevent-
ing its normal function. (A) Overexpressed p127 neither overcomes
suppression of clonal outgrowth by HBx nor restores activity to the
127-binding defective HBx(R96E) mutant. HeLa cells were cotrans-
fected with GFP, or with N-terminal GFP fusions of the indicated HBx
proteins, and equal amounts of empty vector (1vect) or p127. In this
experiment, p127 was overproduced from the Epstein–Barr virus-based
episomal vector EBS-PL, in which the strong Sra promoter drives high
evels of expression (Bontron et al., 1997). Transfection efficiencies and
ygromycin-resistant colony formation were assessed as in Fig. 1B. (B)
he p127-binding defective HBx(R96E) mutant regains activities when
irectly fused to p127. Plasmids expressing GFP or the indicated HBx
roteins in their natural form or as N-terminal fusion to p127 (2p127)
ere transfected into HeLa cells. A GFP gene was cotransfected to
ssess for comparable transfection efficiencies by FACS analysis.
olony formation assay was performed as in Fig. 1B.
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271BINDING OF HBx TO p127 UV-DDB AFFECTS CELL SURVIVALindicate that HBx triggers cell death not simply by se-
questering p127, but rather by endowing it with a dele-
terious activity.
DISCUSSION
In the present study we report on the ability of HBx to
interfere with viability of both primary and immortalized
cells, a property documented to reflect its potential to
induce apoptosis (Chirillo et al., 1997; Su and Schneider,
997; Kim et al., 1998; Terradillos et al., 1998; Shintani et
l., 1999). Our results together with recent findings on
oodchuck hepatitis virus X protein (WHx) reported by
itterlin et al. (2000a) provide compelling evidence that
his activity requires association of HBx with the p127-
Da subunit of UV-DDB. In particular, Sitterlin et al.
2000a) and we (Figs. 3B and 4B) demonstrate using
ifferent mutagenesis approaches a perfect correlation
etween the ability of HBx to bind to p127 and to trigger
ell death. Moreover, Sitterlin et al. (2000a) describe a
ain-of-binding mutant that exerts a trans-dominant neg-
tive effect on wild-type WHx protein. Here we present a
onverse experiment in which the direct fusion of p127 to
p127-binding-defective HBx point mutant restores its
ctivity (Fig. 5B). Collectively, these findings all converge
o the notion that association between these two pro-
eins mediates HBx cytotoxic activities.
As yet we do not know by what mechanisms HBx
ediates its effect. It is unlikely to act solely by stabiliz-
ng p127 and thereby inducing a potentially harmful ac-
umulation of this protein in the cell, because overex-
ression of p127 alone has no deleterious effect on cell
iability (Fig. 5A). HBx must therefore perform a function
hat somehow relates to the physiological role of p127,
hich is not understood. The p127 protein is highly
onserved among species and is expressed in all mam-
alian tissues (Takao et al., 1993), suggesting that it
lays an important role in the cell. It associates with p48
o form UV-DDB that has a function in nucleotide excision
epair (Keeney et al., 1994; Rapic Otrin et al., 1998; Tang
t al., 2000). Yet a role for UV-DDB other than in DNA
epair has also been suggested. In particular, the p48
ubunit of UV-DDB was reported to bind to, and in asso-
iation with p127, stimulate the activity of the transcrip-
ion factor E2F1 that is involved in the expression of cell
ycle genes (Shiyanov et al., 1999). This latter finding is
f particular interest, given that E2F1 promotes either cell
ycle progression or apoptosis, depending on the cellu-
ar environment (DeGregori et al., 1997). This is reminis-
ent of what is observed with HBx (Koike et al., 1994;
enn and Schneider, 1995; Chirillo et al., 1997). Thus,
Bx could be interfering with cell survival by perturbing
ither of these two pathways. However, three observa-
ions are inconsistent with the viral protein acting by
reventing UV-DDB function. First, overexpressed p127
oes not relieve HBx-mediated suppression of colony
n
aormation (Fig. 5A). Second, a p127-binding defective
Bx mutant fused to its target exhibits activities in the
resence of endogenous p127 (Fig. 5B). Third, HBx re-
ains cytotoxic properties in hamster V79 cells that are
ostly defective in UV-DDB activity due to a low level of
48 protein (Tang et al., 2000; data not shown). There-
ore, we favor a model in which HBx exerts its effect not
y sequestering p127, but rather by forcing p127 into a
et to be discovered function or by conferring new activ-
ties to the protein. The simian virus 5 (SV5) V protein has
een recently proposed to affect the cell division cycle
hrough interaction with p127 (Lin and Lamb, 2000). It will
e interesting to determine whether HBx and SV5 V act
hrough similar mechanisms.
structural model for HBx
Previous functional mapping of the 154 amino acid
Bx protein pointed to two distinct regions between
mino acids 50 to 84 and 105 to 142 as being crucial for
ts activities and interactions with cellular proteins (Bar-
abas and Andrisani, 2000, and references therein). Sur-
risingly, however, Sitterlin et al. (2000a) and we identi-
ied residues likely to be directly involved in p127 binding
ithin a segment in between these two regions (black
ectangle in Fig. 3C). A sequence alignment reveals that
his segment is connected to the neighboring regions by
hort amino acid stretches that vary in length and com-
osition between hepadnavirus X proteins. Within the
egment, R96 and L98 are preserved in human and
odent X proteins that were reported to all bind p127 in
east (Sitterlin et al., 1997; Fig. 3C). Whereas mutation of
96 compromises HBx binding to p127, charge reversal
ubstitutions introduced in the neighboring regions re-
ain without effect. Yet in these regions, arginine–pro-
ine insertions are deleterious (Sitterlin et al., 1997; Fig.
C). These observations suggest a model in which the
lanking regions would mainly serve a structural pur-
ose, perhaps through intramolecular interactions, to
llow proper folding and/or positioning of the central
egment that would provide the critical contact points
etween HBx and p127. Insertion mutations, but not sub-
titutions of charged amino acids, would destabilize their
onformations and thereby lead to incorrect folding of
he central protein–protein interaction interface. The
hort amino acid stretches on each side of the internal
egment would serve as hinge or loop regions which can
ccommodate arginine–proline insertion mutations that
ere found to have no effect on p127-binding activity
Sitterlin et al., 1997; Fig. 3C). Consistent with a surface
ocation of the central segment within the native protein,
he analysis of anti-HBx antibody-positive sera from pa-
ients with chronic hepatitis and HCC revealed an immu-
odominant antigenic domain located between amino
cids 85 and 110 (Stemler et al., 1990).
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272 LIN-MARQ ET AL.A possible role for the HBx/p127 complex in liver cancer
HBx plays an essential role in the establishment of
natural viral infection and evidence has been presented
that this function involves interaction with p127 (Sitterlin
et al., 2000b). Although the primary consequence of this
interaction remains elusive, it may translate into apopto-
tic activities at some stage during chronic infection, per-
haps when HBx is made in relatively large amounts from
integrated templates (Feitelson and Duan, 1997). The
HBx/p127-induced cell death would contribute only mar-
ginally to hepatocyte destruction, which is believed to be
largely immune mediated (Nakamoto et al., 1998). Yet it
may play a major role in hepatocarcinogenesis by pro-
viding a selective pressure to favor the emergence of
mutations that relieve HBx/p127-mediated apoptosis and
that might incidentally contribute to tumor promotion.
These mutations may occur in HBx itself or in any cellu-
lar protein required for HBx activity, such as p127. Natural
HBx mutants isolated from tumor liver cells were recently
reported to lack antiproliferative activities (Sirma et al.,
1999). Interestingly, one variant contained three amino
acid mutations, including an R96W substitution that we
found affects interaction with p127 in yeast (data not
shown). HBx point mutants that have lost p127-binding
and cytotoxic activities, however, do not acquire trans-
forming properties in tissue culture cells (data not
shown). Studies aimed at addressing whether specific
mutations in the p127 and/or p48 genes preferentially
accumulate in HCC are under way.
MATERIALS AND METHODS
Expression constructs and mutagenesis
All recombinant DNA work was done according to
standard procedures. Details of the plasmid construc-
tions are available upon request.
The mammalian expression vectors used in this study
were pBJ3, EBO-76PL, and EBS-PL. Plasmid pBJ3 in
which the simian virus 40 (SV40) early enhancer/pro-
moter drives expression was a kind gift of Bruno Amati,
DNAX Research Institute, Palo Alto, CA. The episomal
Epstein–Barr virus-based expression vectors EBO-76PL
and EBS-PL have been described (Bontron et al., 1997).
They carry an optimized hygromycin resistance-confer-
ring gene and permit expression from the SV40 promoter
and the SRa promoter, respectively. GFP produced either
rom pEGFP-C1 (Clontech) or from the GFP open reading
rame cloned into pCI-neo (Promega) was used as a
ontrol to assess for transfection efficiencies.
The region encoding HBx was amplified by reverse
ranscription-polymerase chain reaction (RT-PCR) from
he blood sample of a patient with hepatocellular carci-
oma (kindly provided by Francesco Negro, University of
eneva Medical School, Geneva, Switzerland). A wild-
ype sequence corresponding to the ayw subtype was
e
esolated. A frameshift mutation was introduced at the
nique BamHI site between codons 10 and 11 to produce
Bx(fs). The HBx point mutants were generated in the
BluescriptKS(1) vector (Stratagene) using mutagenic
rimers and the QuickChange site-directed mutagenesis
it (Stratagene) according to the manufacturer’s protocol.
he deletion mutants of HBx were obtained by PCR
mplification. The mutated clones were all confirmed by
equencing of the open reading frame. The deletion
utants of p127 were generated by truncation at the
ollowing naturally occurring restriction endonuclease
ites: XhoI in p127(1–947); EcoRI in p127(200–1140); SphI
in p127(400–1140); and SacI in p127(525–1140). The in-
tegrity of the open reading frame at the junction between
the VP16 and the p127 coding regions was verified by
sequencing. The various fusion constructs were gener-
ated by introducing by PCR convenient restriction endo-
nuclease sites to allow direct subcloning. The constructs
were all first introduced into pBluescriptKS(1) (Strat-
agene) or pUC19 and then cloned into the expression
vectors pBJ3, EBO-76PL, or EBS-PL. The integrity of the
open reading frame at the junction between coding re-
gions was confirmed by sequencing.
The proteins were all expressed from pBJ3 in Fig. 1A,
from EBO-76PL in Fig. 1B, and from EBS-PL in Fig. 5B.
GFP-p127 was expressed from pBJ3 in Fig. 4A. The native
p127 protein was overproduced from EBS-PL in Fig. 5A.
GFP-HBx and GFP-HBx(R96E) were expressed from
EBO-76PL in Figs. 4A and 5A. GFP was made from
EBO-76PL in Fig. 5A; wild-type and mutant HBx proteins
were produced from EBO-76PL in Fig. 4B. The Western
blot analysis presented in Fig. 4C was with wild-type and
mutant HBx expressed as GFP fusion proteins from pBJ3.
Yeast two-hybrid and b-galactosidase assay
The construction of the VP16 activation domain-tagged
cDNA library derived from the human B lymphoid cell line
Namalwa has been described (Strubin et al., 1995). The
DNA library made with mRNA from the human B-cell
ine Raji was a generous gift from Walter Reith (University
f Geneva Medical School, Geneva, Switzerland) and
iktor Steimle (Max-Planck-Institute of Immunology,
reiburg, Germany). Both libraries were expressed from
centromeric plasmid marked with the TRP1 gene under
he control of the galactose-inducible GAL1,10 regulatory
equences (Strubin et al., 1995).
HBx was joined in frame to the carboxyl- or amino-
erminus of RFX (Gonzalez-Couto et al., 1997) to produce
FX-HBx and HBx-RFX, respectively. These constructs
ere inserted into a URA3 centromeric plasmid between
he regulatory sequences derived from the yeast TBP gene.
The two-hybrid screen was performed essentially as
escribed (Strubin et al., 1995), with the following differ-
nces. The two yeast strains that were used as reporter
xpress either RFX-HBx or HBx-RFX as bait and contain
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llele bearing a single RFX-binding site upstream of the
ATA element (Gonzalez-Couto et al., 1997). Each strain
was transformed with the VP16-cDNA fusion libraries;
the primary transformants (a total of 15 3 106) were
screened for aminotriazole-resistant colonies, and the
library plasmids were recovered from the positive trans-
formants exactly as reported previously (Strubin et al.,
1995). The cDNA inserts were identified as correspond-
ing to the mRNA encoding p127 by partial sequencing
with a forward primer hybridizing to the region corre-
sponding to the C-terminal end of the VP16 activation
domain.
The b-galactosidase assays were performed in a
east strain carrying an RFX-dependent lacZ reporter
ene integrated at the HIS3 locus. Transformed yeast
ells were grown to early log phase in selective medium
nd assayed for b-galactosidase activity as described
elsewhere (Gonzalez-Couto et al., 1997).
Cells, transfections, and colony-forming assay
Primary REFs (a kind gift of Bruno Amati) and HeLa
cells were maintained in Dulbecco’s modified Eagle’s
medium (DMEM) (Gibco-BRL) supplemented with 100
U/ml penicillin, 100 mg/ml streptomycin, 2 mM L-glu-
amine, and 10% v/v fetal calf serum (FCS) in a 5% CO2
incubator at 37°C. Transfections of REFs cells were
performed according to the calcium phosphate precipi-
tation method. A total of 10 mg of plasmid DNA per 10-cm
late was used. At 36 h posttransfection, the cells were
plit 1:6 into DMEM containing 10% FCS and 1 mg/ml
uromycin (Sigma). Drug-resistant colonies appearing
0–15 days later were fixed in 20% methanol and stained
ith 0.1% crystal violet (Sigma). HeLa cells were trans-
ected by seeding the cells at a density of 105 cells per
5-mm dish the day before transfection. Transfections
ere performed using FuGENE 6 (Roche) at a ratio of 3
ml of FuGENE 6 per microgram of DNA, according to the
manufacturer’s instructions. The total amount of DNA
was kept constant in all transfections by supplementing
vector DNA. At 24 h posttransfection, cells were
trypsinized and a fraction (usually 1/3) was scanned by
FACS for GFP fluorescence to assess for transfection
efficiencies; transfection efficiencies were generally 50–
80% with variations of less than 10% within any single
experiment. The remaining cells were replated at lower
density and grown into selection medium containing 150
mg/ml of hygromycin B (Calbiochem). After 8–12 days,
drug-resistant cells were washed with PBS and stained
with crystal violet.
Analysis of cell extracts by Western blotting
Cells were lysed in 50 mM Tris–HCl pH 7.4, 250 mM
NaCl, 1 mM EDTA, 0.1% Triton X-100, 0.5 mM phenylmeth-
ylsulfonyl fluoride (PMSF), and a mixture of proteaseinhibitors. The lysates were cleared by centrifugation at
14,000 rpm for 20 min at 4°C. About 10 mg of total cellular
protein was separated on 10% SDS–PAGE and trans-
ferred electrophoretically to Immobilon P membrane
(Millipore) in a Bio-Rad Trans-Blot semidry transfer cell
according to the manufacturer’s directions. The mem-
brane was blocked in 2% Roche blocking reagent for 30
min and then probed in the same buffer with 1:1000
anti-GFP polyclonal antibody (IgG fraction) (Clontech)
overnight at 4°C. After another 1 h incubation at room
temperature, the blot was washed six times for 5 min
each in TBS with 0.05% Tween 20. Binding of primary
antibody was detected in the same buffer with horserad-
ish peroxidase-conjugated anti-rabbit IgG antibody (ECL,
Amersham) diluted 1:5000 and visualized with chemilu-
minescent reagents (Lumi-Light Western blotting sub-
strate, Roche).
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